Litcius/Paper detail

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection

Richard J. Mills, Sean J. Humphrey, Patrick R.J. Fortuna, Mary Lor, Simon R. Foster, Gregory A. Quaife-Ryan, Rebecca L. Johnston, Troy Dumenil, Cameron Bishop, Rajeev Rudraraju, Daniel J. Rawle, Thuy T. T. Le, Wei Zhao, Leo Lee, Charley Mackenzie-Kludas, Neda R. Mehdiabadi, Christopher Halliday, Dean Gilham, Li Fu, Stephen J. Nicholls, Jan O. Johansson, Michael Sweeney, Norman C.W. Wong, Ewelina Kulikowski, Kamil A. Sokolowski, Brian Wan-Chi Tse, Lynn Devilée, Holly K. Voges, Liam Reynolds, Sophie Krumeich, Ellen Mathieson, Dad Abu-Bonsrah, Kathy Karavendzas, Brendan Griffen, Drew M. Titmarsh, David A. Elliott, James McMahon, Andreas Suhrbier, Kanta Subbarao, Enzo R. Porrello, Mark J. Smyth, Christian Engwerda, Kelli P. A. MacDonald, Tobias Bald, David E. James, James E. Hudson

2021Cell233 citationsDOIOpen Access PDF

Topics & Concepts

BiologyInflammationBromodomainCytokine stormCardiac dysfunctionImmunologyMyocarditisCytokineHMGB1Viral MyocarditisVirusInternal medicineCoronavirus disease 2019 (COVID-19)Heart failureGeneMedicineInfectious disease (medical specialty)DiseaseAcetylationGeneticsProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisAdvancements in Semiconductor Devices and Circuit Design